The above-mentioned data suggest that a high PCSK9 level could play a key role in liver lipid storage and metabolism of TG, thus contributing to the pathogenesis of NAFLD. This evidence concerns the gene PCSK9 and metabolic dysfunction-associated steatotic liver disease.